- Home
- FATE vs QTRX Comparison
FATE vs QTRX Comparison
Compare FATE & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FATE
- QTRX
- Stock Information
- Founded
- FATE 2007
- QTRX 2007
- Country
- FATE United States
- QTRX United States
- Employees
- FATE N/A
- QTRX N/A
- Industry
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- FATE Health Care
- QTRX Industrials
- Exchange
- FATE Nasdaq
- QTRX Nasdaq
- Market Cap
- FATE 406.5M
- QTRX 439.1M
- IPO Year
- FATE 2013
- QTRX 2017
- Fundamental
- Price
- FATE $2.02
- QTRX $11.44
- Analyst Decision
- FATE Buy
- QTRX Strong Buy
- Analyst Count
- FATE 11
- QTRX 4
- Target Price
- FATE $6.89
- QTRX $23.25
- AVG Volume (30 Days)
- FATE 1.6M
- QTRX 462.6K
- Earning Date
- FATE 11-12-2024
- QTRX 11-12-2024
- Dividend Yield
- FATE N/A
- QTRX N/A
- EPS Growth
- FATE N/A
- QTRX N/A
- EPS
- FATE N/A
- QTRX N/A
- Revenue
- FATE $13,447,000.00
- QTRX $129,330,000.00
- Revenue This Year
- FATE N/A
- QTRX $13.56
- Revenue Next Year
- FATE N/A
- QTRX $16.49
- P/E Ratio
- FATE N/A
- QTRX N/A
- Revenue Growth
- FATE N/A
- QTRX 15.52
- 52 Week Low
- FATE $1.96
- QTRX $10.50
- 52 Week High
- FATE $8.83
- QTRX $29.70
- Technical
- Relative Strength Index (RSI)
- FATE 31.10
- QTRX 35.72
- Support Level
- FATE $2.33
- QTRX $14.72
- Resistance Level
- FATE $2.58
- QTRX $15.46
- Average True Range (ATR)
- FATE 0.25
- QTRX 0.96
- MACD
- FATE -0.04
- QTRX -0.27
- Stochastic Oscillator
- FATE 6.45
- QTRX 4.94
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.